MedTrace Logo

Proof-of-Concept Study of the SNOEZELEN Device on Anxiety Symptoms in Patients Hospitalized for Chemotherapy in a Pediatric Oncology Department

NCT07202507 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2026-03-18

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate whether the Snoezelen multisensory relaxation approach can reduce anxiety symptoms in children and adolescents aged 8 to 17 years hospitalized for chemotherapy in a pediatric oncology unit.

Researchers will compare patients' symptoms during a chemotherapy cycle with Snoezelen sessions to a previous cycle without Snoezelen, in order to assess changes in psychological and physical well-being.

Participants will:

* Be enrolled between their first (without Snoezelen) and second (with Snoezelen) chemotherapy cycles
* Complete self-report questionnaires on anxiety, depression, quality of life, and nausea
* Receive 45-minute Snoezelen sessions every two days during their second hospitalization
* Participate in a semi-structured interview after the final session
* Provide data on medications (anxiolytics, antiemetics) and vomiting frequency during both hospitalizations

Conditions

  • Snoezelen
  • Pediatric Cancer
  • Symptomatologie Anxieuse
  • Chimiothérapie

Interventions

OTHER

self-report questionnaires, research interviews

self-report questionnaires and research interviews

Sponsors & Collaborators

  • PETRARQUE

    collaborator UNKNOWN

  • Scalab CNRS 9193

    collaborator OTHER

  • Centre Oscar Lambret

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-09-30
Primary Completion
2027-10-31
Completion
2027-10-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07202507 on ClinicalTrials.gov